Q: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Description: The Chemical can be represented with the SMILES CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1.
Result: Clinical Phase unknown
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1
CCCCCCCCNC(=N)NC(=N)NCc1ccc(Cl)c(Cl)c1
1-[N-[(3,4-dichlorophenyl)methyl]carbamimidoyl]-3-octyl-guanidine
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Clinical Phase unknown